1.
Hallacli E, Kayatekin C, Nazeen S, et al. The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 2022;185(12):2035-2056.e33. doi:10.1016/j.cell.2022.05.008.
1.
Beaudoin J-D, Novoa EM, Vejnar CE, et al. Analyses of mRNA structure dynamics identify embryonic gene regulatory programs. Nat Struct Mol Biol. 2018;25(8):677-686. doi:10.1038/s41594-018-0091-z.
1.
Zimmer M, Ebert BL, Neil C, et al. Small-molecule inhibitors of HIF-2a translation link its 5’UTR iron-responsive element to oxygen sensing. Mol Cell. 2008;32(6):838-48. doi:10.1016/j.molcel.2008.12.004.
1.
Kim WK, Yun S, Kwon Y, et al. mRNAs containing NMD-competent premature termination codons are stabilized and translated under UPF1 depletion. Sci Rep. 2017;7(1):15833. doi:10.1038/s41598-017-16177-9.
1.
Rabani M, Pieper L, Chew G-L, Schier AF. A Massively Parallel Reporter Assay of 3’ UTR Sequences Identifies In Vivo Rules for mRNA Degradation. Mol Cell. 2017;68(6):1083-1094.e5. doi:10.1016/j.molcel.2017.11.014.
1.
Schier AF. The maternal-zygotic transition: death and birth of RNAs. Science. 2007;316(5823):406-7. doi:10.1126/science.1140693.
1.
Janas MM, Novina CD. Not lost in translation: stepwise regulation of microRNA targets. EMBO J. 2012;31(11):2446-7. doi:10.1038/emboj.2012.119.
1.
Rouskin S, Zubradt M, Washietl S, Kellis M, Weissman JS. Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo. Nature. 2014;505(7485):701-5. doi:10.1038/nature12894.
1.
Schwartz S, Mumbach MR, Jovanovic M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5’ sites. Cell Rep. 2014;8(1):284-96. doi:10.1016/j.celrep.2014.05.048.
1.
Paraboschi EM, Rimoldi V, Soldà G, et al. Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Hum Mol Genet. 2014;23(25):6746-61. doi:10.1093/hmg/ddu392.